Trading Halt for Mayne Pharma Group
Key points
- Trading in MYX securities halted at the company's request
- Halt pending announcement of Court of Appeal decision
- Decision related to Cosette's appeal of Supreme Court judgement
- Halt to remain in place until 16 October 2026 or announcement release
Full summary
Mayne Pharma Group Limited (ASX: MYX) has requested a trading halt in its securities in accordance with Listing Rule 17.1. The halt is pending the release of an announcement related to the Court of Appeal's decision in Cosette's appeal of the Supreme Court of New South Wales judgement delivered on 15 October 2025. The Court of Appeal's decision is scheduled to be handed down after market open on 14 October 2026. The securities will remain in trading halt until the earlier of the commencement of normal trading on 16 October 2026 or when the announcement is released to the market.
Summary generated by a large language model. Please interpret with care.